News

The FDA grants orphan designation to products that are intended to address diseases affecting fewer than 200,000 persons in the US. If oral fludarabine receives FDA approval, this

The Master-VU System consists of a B-scan probe that can be interfaced to a standard personal computer (via a USB cable connection) using Sonomed’s proprietary software, thereby converting

Patients who have completed the six months trial were provided the opportunity to continue treatment with ISA247 as part of an extension to the initial trial. This six-month

According to BenOra, this acquisition will allow the company to accelerate the goal of bringing state-of-the-art technology to a larger patient population in central Arizona. Solis Women’s Health

The court has denied Pfizer’s request to prevent Apotex from launching a generic version of Lipitor prior to the expiration of Pfizer’s enantiomer (calcium salt) patent in July

Luminex said that xTAG respiratory viral panel (RVP) is a groundbreaking viral assay that, with a single patient sample, can assess the presence or absence of 12 viral

The TIME registration program is designed to include two trials, a pivotal Phase III trial (TIME-1) and a smaller supportive trial. The TIME-1 trial is proceeding on track

The FDA grants orphan drug designation to products that are intended to treat rare or ‘orphaned’ diseases or conditions such as Lennox-Gastaut syndrome (LGS). Tim Cunniff, vice president,

According to WuXi, the acquisition of AppTec will allow the company to immediately obtain biologics capabilities and expertise, gain a significant US operational footprint and expand its customer